Updated Jul 16, 2026
Melincoff Gwen A is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Gwen A. Melincoff is associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics based on its proprietary ProCellEx platform. Specific details regarding her role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | A — Grant or award | 7.5K | — |
Gwen A. Melincoff is associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics based on its proprietary ProCellEx platform. Specific details regarding her role and contributions to the company are not widely documented.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Melincoff Gwen A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.